Conformational Features of Beta-Amyloid Peptide 25–35

被引:0
|
作者
Agaeva G.A. [1 ]
Najafova G.Z. [2 ]
机构
[1] Institute for Physical Problems, Baku State University, Baku
[2] French-Azerbaijani University, Baku
关键词
beta-amyloid peptide 25–35; conformation; molecular dynamics method; molecular mechanics method;
D O I
10.1134/S0006350923050020
中图分类号
学科分类号
摘要
Abstract: Beta-amyloid peptide (Aβ) plays an important role in the mechanism of neurodegeneration in Alzheimer’s disease. A fragment of beta-Aβ(25–35) amyloid peptide with the sequence GSNKGAIIGLM is considered to be the functional domain of the amyloid Aβ peptide responsible for its neurotoxic properties and the biologically active Aβ region. Conformational analysis by the method of molecular mechanics of each peptide segment of the C-terminal part of the peptide revealed a limited number of the most probable conformations and clearly defined the forces stabilizing the structures. The results we obtained showed that the Aβ(25–35) peptide energetically preferentially adopts the a-helical conformation at the C-terminal octapeptide segment. The molecular dynamics method was used to model the intramolecular mobility pattern of the Aβ(25–35) peptide molecule. It is shown that in the low-energy conformations of the Aβ(25–35) peptide, the flexible structures in its N-terminal region were oriented differently with respect to the structures in the C-terminal part. © Pleiades Publishing, Inc. 2023. ISSN 0006-3509, Biophysics, 2023, Vol. 68, No. 5, pp. 712–718. Pleiades Publishing, Inc., 2023. Russian Text The Author(s), 2023, published in Biofizika, 2023, Vol. 68, No. 5, pp. 871–877.
引用
收藏
页码:712 / 718
页数:6
相关论文
共 50 条
  • [31] Standardized extract of Centella asiatica ECa 233 improved cognitive deficits induced by beta-amyloid peptide (25-35)
    Tantisira, Mayuree H.
    Kam-Eg, Anchalee
    Tantisira, Boonyong
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 91P - 91P
  • [32] TOXIC EFFECT OF A BETA-AMYLOID PEPTIDE (BETA-22-35) ON THE HIPPOCAMPAL NEURON AND ITS PREVENTION
    TAKADERA, T
    SAKURA, N
    MOHRI, T
    HASHIMOTO, T
    NEUROSCIENCE LETTERS, 1993, 161 (01) : 41 - 44
  • [33] KINETICS OF AGGREGATION OF SYNTHETIC BETA-AMYLOID PEPTIDE
    TOMSKI, SJ
    MURPHY, RM
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 294 (02) : 630 - 638
  • [34] BETA-AMYLOID PEPTIDE DECREASES MEMBRANE FLUIDITY
    MULLER, WE
    KOCH, S
    ECKERT, A
    HARTMANN, H
    SCHEUER, K
    BRAIN RESEARCH, 1995, 674 (01) : 133 - 136
  • [35] ACTIVATION OF MACROPHAGES BY ALZHEIMER BETA-AMYLOID PEPTIDE
    KLEGERIS, A
    WALKER, DG
    MCGEER, PL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (02) : 984 - 991
  • [36] Beta-amyloid peptide-a calcium antagonist?
    Palotas, A
    Kalman, J
    Palotas, M
    Juhasz, A
    Janka, Z
    Penke, B
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2002, 45 (1-2) : 143 - 143
  • [37] SELF-ASSEMBLY OF BETA-AMYLOID PEPTIDE
    SHEN, CL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 25 - PHYS
  • [38] The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide
    Ashur-Fabian, O
    Segal-Ruder, Y
    Skutelsky, E
    Brenneman, DE
    Steingart, RA
    Giladi, E
    Gozes, I
    PEPTIDES, 2003, 24 (09) : 1413 - 1423
  • [39] BETA-AMYLOID 25-35 ACTIVATES NITRIC-OXIDE SYNTHASE IN A NEURONAL CLONE
    HU, JR
    ELFAKAHANY, EE
    NEUROREPORT, 1993, 4 (06) : 760 - 762
  • [40] APOPTOSIS MEDIATED NEUROTOXICITY INDUCED BY CHRONIC APPLICATION OF BETA-AMYLOID FRAGMENT 25-35
    FORLONI, G
    CHIESA, R
    SMIROLDO, S
    VERGA, L
    SALMONA, M
    TAGLIAVINI, F
    ANGERETTI, N
    NEUROREPORT, 1993, 4 (05) : 523 - 526